BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Villamil FG. Hepatitis B: progress in the last 15 years. Liver Transpl. 2002;8:S59-S66. [PMID: 12362301 DOI: 10.1053/jlts.2002.35782] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Kelly D. Viral Hepatitis in Children. In: Pollard AJ, Mccracken GH, Finn A, editors. Hot Topics in Infection and Immunity in Children. Boston: Springer US; 2004. pp. 83-90. [DOI: 10.1007/978-1-4419-8993-2_12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Neff GW, Sherman KE. Post-transplant hepatitis: HCV and HBV. Curr hepatitis rep 2004;3:98-104. [DOI: 10.1007/s11901-004-0016-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Oh YJ, Park YM, Hong SP, Shin SK, Ji SI, Kim BH, Park SJ, Hong Z. A YIDD Mutation in a Case of Recurrent Hepatitis B after Liver Transplantation Induced by an S-escape Mutant. Gut Liver 2010;4:253-7. [PMID: 20559531 DOI: 10.5009/gnl.2010.4.2.253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Moriconi F, Colombatto P, Coco B, Ciccorossi P, Oliveri F, Flichman D, Maina AM, Sacco R, Bonino F, Brunetto MR. Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. J Antimicrob Chemother. 2007;60:341-349. [PMID: 17567633 DOI: 10.1093/jac/dkm187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
5 Jiang Z, Feng X, Zhang W, Gao F, Ling Q, Zhou L, Xie H, Chen Q, Zheng S. Recipient cytotoxic T lymphocyte antigen -4+ 49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Liver Int. 2007;27:1202-1208. [PMID: 17919231 DOI: 10.1111/j.1478-3231.2007.01553.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
6 Lin LM, Kuo SC, Chiu YC, Lin HF, Kuo ML, Elsarawy AM, Chen CL, Lin CC. Cost Analysis and Determinants of Living Donor Liver Transplantation in Taiwan. Transplant Proc 2018;50:2601-5. [PMID: 30401359 DOI: 10.1016/j.transproceed.2018.03.061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Neff GW, Kemmer N, Kaiser TE, Zacharias VC, Alonzo M, Thomas M, Buell J. Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin. Dig Dis Sci. 2007;52:2497-2500. [PMID: 17404847 DOI: 10.1007/s10620-006-9658-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mas A, Castells L, Abradelo M, Bernardos Á, Páez A, Woodward M, Sousa J. Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation. Transplantation Proceedings 2009;41:4253-8. [DOI: 10.1016/j.transproceed.2009.09.083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
9 Gish RG, McCashland T. Hepatitis B in liver transplant recipients. Liver Transpl. 2006;12:S54-S64. [PMID: 17051551 DOI: 10.1002/lt.20950] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
10 Hilleman MR. Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine. 2003;21:4626-4649. [PMID: 14585670 DOI: 10.1016/s0264-410x(03)00529-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
11 Neff GW, O’brien CB, Nery J, Shire N, Montalbano M, Ruiz P, Nery C, Safdar K, De Medina M, Tzakis AG. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Liver Transpl. 2004;10:1372-1378. [PMID: 15497163 DOI: 10.1002/lt.20277] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.0] [Reference Citation Analysis]
12 Cheng H, Zhang HZ, Shen WA, Liu YF, Ma FC. Expression of RNase H of human hepatitis B virus polymerase in Escherichia coli. World J Gastroenterol 2003;9:513-5. [PMID: 12632508 DOI: 10.3748/wjg.v9.i3.513] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant. 2005;5:549-557. [PMID: 15707410 DOI: 10.1111/j.1600-6143.2005.00741.x] [Cited by in Crossref: 138] [Cited by in F6Publishing: 112] [Article Influence: 8.6] [Reference Citation Analysis]
14 Targhetta S, Villamil F, Inturri P, Pontisso P, Fagiuoli S, Cillo U, Cecchetto A, Gianni S, Naccarato R, Burra P. Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease. World J Gastroenterol 2006;12:1706-12. [PMID: 16586538 DOI: 10.3748/wjg.v12.i11.1706] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
15 Jun-bin S, Zhi C, Wei-qin N, Jun F. A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction. Journal of Virological Methods 2003;112:45-52. [DOI: 10.1016/s0166-0934(03)00190-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
16 Pei F, Ning JY, You JF, Yang JP, Zheng J. YMDD variants of HBV DNA polymerase gene: rapid detection and clinicopathological analysis with long-term lamivudine therapy after liver transplantation. World J Gastroenterol 2005;11:2714-9. [PMID: 15884109 DOI: 10.3748/wjg.v11.i18.2714] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]